iShares Health Innovation Active ETF BMED
Set alert
36.10 USD -0.40 -1.08%
At close · Nov 2
36.10 0.00 0.00%
After hours · Nov 2, 4:04 PM ET
36.07 Day range 36.52
27.25 52-week range 36.98
- YTD
- +19.07%
- 1 year
- +26.59%
- Open
- 36.51
- Prev close
- 36.50
- Mkt cap
- 14.60M
- Vol
- 2.42K
- Avg vol
- 2.16K
- EPS
- 1.02
- P/E
- 35.41
- Div yield
- 0.00%
More statistics
- Low
- 36.07
- High
- 36.52
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 25.76
- 200-d avg
- 25.58
2Y chart
Events in this range
- Jun 15, 2026Dividend: 0.08118
Signals (80)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| RSI: Overbought | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| SMA: Bearish | Jun 10, 2026 | 4 months ago |
| SMA: Bullish | Jun 9, 2026 | 4 months ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| SMA: Bullish | May 28, 2026 | 5 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 24, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
Newest 20 of 80.
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 31.23
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 25.76
- 200-day average
- 25.58
About iShares Health Innovation Active ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
News
- 3 Longevity ETFs to Buy and Hold (and Hold)
- World Health Organization Responds to Trump's Order, Reminds Decades of Successful Health Achievements
- Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
- Can Health Care Stocks Outperform Again In 2023?
- BlackRock Releases Megatrends Report
- Medical Device ETF Debuts
Your note
Sign in to keep a note on BMED — it syncs with the Stock Master app.